Best Practices In KOL & Prescriber Management In Oncology, 19-20 November 2012, Belgium

Date: Aug-21-2012This will be the only oncology focused event looking at new commercial models & strategies to communicate & engage with Key Opinion Leaders (KOLs) and key prescribers. One of the goals will be to improve seamless coordination between all internal & external stakeholders in strategic, operational and tactical roles. The latest "best practices" in communicating the value of cost for cancer therapeutics to KOLs & prescribers will be explored from multiple perspectives. The event will also examine working in partnership with therapeutic specialists, pharmacists, prescribers as well as other stakeholders such as payers and hospitals /healthcare providers to provide real value, strong communication and to improve patient access.

Why attend?
Hear specific examples & focused case studies from across oncology indication areas on how to best develop new business models.
Learn what do specialist prescribers want and how can we better communicate value?
Find out what are the most effective communication channels to interact with Key Opinion Leaders, and today's new specialty stakeholders.
Consider how to best incorporate all stakeholders' insights, needs and analysis into future drug development and post-marketing phases to maximize product lifecycle.
Understand the benefits and how to interact with KOLs through online social communities.
Agenda request

To request the full agenda please follow this link.

Conference Dates: 19th-20th November, 2012

Venue: Brussels, Belgium

For Booking Information contact:

Erika Vavrovicova

Tel: +421 232 660 382

Fax: +421 2 3301 0331

Email: erika@nextlevelpharma.com

Visit: http://www.nextlevelpharma.com

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.